Literature DB >> 19870855

ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI.

G K Hirst1, R C Lancefield.   

Abstract

1. A substance extracted from group A hemolytic streptococcus is described, which induces active immunity in mice, and in rabbits gives rise to precipitins and to protective antibodies passively transferable to mice. 2. The active immunity in mice is principally type-specific, but some degree of non-type-specific immunity is also developed. The passively transferable protective antibodies are type-specific with only a slight suggestion of non-type specificity. In the precipitin test, the rabbit immune sera give both type-specific and non-type-specific reactions which have not been fully analyzed serologically. 3. Substances contained in the extract absorb the protective antibodies from the serum of rabbits immunized with whole hemolytic streptococci. 4. The most satisfactory method of extraction so far developed is fully described. Chemical tests on the material are consistent with the presence of protein and nucleic acid. 5. The type-specific M substance, prepared as previously described, was compared in some of its antigenic properties with the above mentioned substance. It was found capable of inducing active immunity in mice and of absorbing protective antibody from anti-bacterial immune serum in a manner qualitatively similar to that obtained with the preparations made by the newer methods.

Entities:  

Year:  1939        PMID: 19870855      PMCID: PMC2133746          DOI: 10.1084/jem.69.3.425

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Capsules in Young Cultures of Streptococcus hemolyticus.

Authors:  C V Seastone
Journal:  J Bacteriol       Date:  1934-11       Impact factor: 3.490

2.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

3.  STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  A R Dochez; O T Avery; R C Lancefield
Journal:  J Exp Med       Date:  1919-09-01       Impact factor: 14.307

4.  PROTEIN FRACTIONS OF A SCARLATINAL STRAIN OF STREPTOCOCCUS HEMOLYTICUS.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

5.  STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : I. OBSERVATIONS ON THE VIRULENT, ATTENUATED, AND AVIRULENT VARIANTS.

Authors:  H K Ward; C Lyons
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

6.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : II. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE PROTEIN FRACTIONS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

  6 in total
  24 in total

1.  New protective antigen of group A streptococci.

Authors:  J B Dale; E Y Chiang; S Liu; H S Courtney; D L Hasty
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Structural vaccinology to thwart antigenic variation in microbial pathogens.

Authors:  Olaf Schneewind; Dominique Missiakas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

3.  Recurrent sepsis caused by Streptococcus pyogenes.

Authors:  Magnus Rasmussen
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

4.  Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.

Authors:  J B Dale; E H Beachey
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan.

Authors:  Tadayoshi Ikebe; Akihito Wada; Yoshishige Inagaki; Kumiko Sugama; Rieko Suzuki; Daisuke Tanaka; Aki Tamaru; Yoshihiro Fujinaga; Yoshiaki Abe; Yoshikata Shimizu; Haruo Watanabe
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

7.  Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.

Authors:  Mengyao Liu; Hui Zhu; Jinlian Zhang; Benfang Lei
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

8.  Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus.

Authors:  R C LANCEFIELD; G E PERLMANN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

9.  Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.

Authors:  E H Beachey; G H Stollerman; R H Johnson; I Ofek; A L Bisno
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  THE EFFECT OF A POLYSACCHARIDE-SPLITTING ENZYME ON STREPTOCOCCAL INFECTION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1941-03-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.